1301256-48-3

Upstream product

• 1301256-30-3 2-[4-(N-methyl-N-Boc-amino)phenyl]-6-hydroxylbenzo[b]thiophene 
• 106-95-6 allyl bromide 
• 19301-39-4 1-benzothiophen-6-ol 
• 1301256-12-1 6-(t-butyldimethylsilyloxy)benzo[b]thiophene-2-boronic acid 
• 1301256-11-0 6-(t-butyldimethylsilyloxy)benzo[b]thiophene 
• 1301256-20-1 2-[4-(N-methyl-N-Boc-amino)phenyl]-6-(t-butyldimethylsilyloxy)benzo[b]thiophene 

Downstream Products

• 1301256-86-9 2-[4-(N-methyl-N-Boc-amino)phenyl]-6-[3-methanesulfonyloxy-2-(tetrahydropyran-2-yloxy)propoxy]benzo[b]thiophene 
• 1301256-57-4 2-[4-(N-methyl-N-Boc-amino)phenyl]-6-(2,3-dihydroxypropoxy)benzo[b]thiophene 
• 1301255-93-5 2-[4-(methylamino)phenyl]-6-(3-fluoro-2-hydroxypropoxy)benzo[b]thiophene 
• 1301256-69-8 2-[4-(N-methyl-N-Boc-amino)phenyl]-6-(3-methanesulfonyloxy-2-hydroxypropoxy)benzo[b]thiophene 

Relevant academic research and scientific papers

(3-FLUORO-2-HYDROXY)PROPYL-FUNCTIONALIZED ARYL DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR THE DIAGNOSIS OR TREATMENT OF NEURODEGENERATIVE BRA

The present invention relates to (3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or to the pharmaceutically acceptable salt thereof, to a method for preparing same, and to a pharmaceutical composition containing same as active ingredients for t